D-lysergic acid diethylamide (LSD)1mL of ethanol95% Vol.
Eligibility
Age group
18-64 years
Sex
Female, Male
Primary endpoint
ADHD symptoms, Emotion regulation, Sleep
Endpoint detail
Pharmacokinetic profile, Theta-beta power ratio, CYP2D6 functionality, Polygenic risk score
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.